85 related articles for article (PubMed ID: 11876553)
1. A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer.
Przybylowska K; Smolarczyk K; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B
J Exp Clin Cancer Res; 2001 Dec; 20(4):569-72. PubMed ID: 11876553
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor 1 (PAI-1) 1334G/A genetic polymorphism in colorectal cancer.
Smolarz B; Romanowicz-Makowska H; Kulig A
Acta Biochim Pol; 2003; 50(2):489-95. PubMed ID: 12833173
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
Smolarz B; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B; Szewczyk T
J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer.
Wu CY; Wu MS; Chen YJ; Chen HP; Chen CJ; Chang CS; Lin JT
Hepatogastroenterology; 2008; 55(86-87):1890-4. PubMed ID: 19102416
[TBL] [Abstract][Full Text] [Related]
5. Distribution of C-->T and T-->C polymorphisms of the urokinase-type plasminogen activator gene in children with type 1 diabetes mellitus and insulin resistance.
Majsterek I; Przybylowska K; Mlynarski W; Drzewoski J; Blasiak J
Clin Exp Med; 2005 Mar; 4(4):202-6. PubMed ID: 15750768
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.
Blasiak J; Przybyłowska K; Czechowska A; Zadrozny M; Pertyński T; Rykała J; Kołacińska A; Morawiec Z; Drzewoski J
Acta Biochim Pol; 2003; 50(1):249-53. PubMed ID: 12673366
[TBL] [Abstract][Full Text] [Related]
7. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
9. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
10. [Association between vascular endothelial growth factor gene 936 T/C polymorphism and colorectal cancer together with anastomotic leakage].
Wu GY; Wang XM; Keese M; Hasenberg T; Sturm JW
Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1505-7. PubMed ID: 17349182
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma.
Kuwai T; Kitadai Y; Tanaka S; Kuroda T; Ochiumi T; Matsumura S; Oue N; Yasui W; Kaneyasu M; Tanimoto K; Nishiyama M; Chayama K
Oncol Rep; 2004 Nov; 12(5):1033-7. PubMed ID: 15492789
[TBL] [Abstract][Full Text] [Related]
12. Antigen levels of urokinase-type plasminogen activator receptor and its gene polymorphism related to microvessel density in colorectal cancer.
Przybylowska K; Szemraj J; Kulig A; Dziki A; Ulanska J; Blasiak J
Acta Biochim Pol; 2008; 55(2):357-63. PubMed ID: 18511987
[TBL] [Abstract][Full Text] [Related]
13. Antigen levels of the urokinase-type plasminogen activator and its gene polymorphisms in colorectal cancer.
Przybyłowska K; Smolarczyk K; Kulig A; Romanowicz-Makowska H; Dziki A; Ulańska J; Pander B; Błasiak J
Cancer Lett; 2002 Jul; 181(1):23-30. PubMed ID: 12430175
[TBL] [Abstract][Full Text] [Related]
14. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Niewiadomski M; Kozlowska E; Kulig A
J Exp Clin Cancer Res; 2002 Sep; 21(3):357-61. PubMed ID: 12385578
[TBL] [Abstract][Full Text] [Related]
15. Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer.
Romanowicz-Makowska H; Smolarz B; Kulig A
Pol J Pathol; 2005; 56(4):161-5. PubMed ID: 16477874
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
[TBL] [Abstract][Full Text] [Related]
17. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma.
Weng CJ; Tsai CM; Chen YC; Hsieh YH; Lin CW; Liu YF; Su SC; Chen MK; Yang SF
Ann Surg Oncol; 2010 Dec; 17(12):3394-401. PubMed ID: 20706793
[TBL] [Abstract][Full Text] [Related]
19. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.
Smolarz B; Szyłło K; Romanowicz-Makowska H; Niewiadomski M; Kozłowska E; Kulig A
Pol J Pathol; 2003; 54(4):233-8. PubMed ID: 14998290
[TBL] [Abstract][Full Text] [Related]
20. p16INK4a polymorphism: associations with tumour progression in patients with sporadic colorectal cancer.
McCloud JM; Sivakumar R; Greenhough A; Elder J; Jones PW; Deakin M; Elder JB; Fryer AA; Hoban PR
Int J Oncol; 2004 Nov; 25(5):1447-52. PubMed ID: 15492837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]